In The News
ACCC takes Magnamail to court for misleading prize promotions
Optus slapped with $12m penalty over Triple-0 outage
High Court to resolve uncertainty over common fund orders
‘Influx’ of consumer class actions likely after High Court’s Toyota decision, lawyer says
‘Eye-watering’ legal costs in NT stolen wages class action: judge
ASIC launches formal MinRes probe over Ellison tax dodge claims
Judge grounds Moccona’s infringement claims over Vittoria’s coffee jar design
Government to ban social media for kids under 16
Partner numbers at consulting firms should be capped in wake of PwC scandal: report
‘Study help’ platform Chegg faces first-ever case over academic cheating
Please login to bookmarkClose

Switzerland-based Biogen has sued generic drug maker MSN Laboratories for allegedly threatening to infringe the patent for its top-selling oral MS drug Tecfidera.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au